Zhang H - Search Results

1

The Potential Role of Metabolic Disease in Liver Tumorigenesis in Patients With Hepatitis B Surface Antigen Seroclearance.

Zhang H, Zeng W. Zhang H, et al. Clin Gastroenterol Hepatol. 2019 May;17(6):1216-1217. doi: 10.1016/j.cgh.2018.11.020. Clin Gastroenterol Hepatol. 2019. PMID: 31003698 No abstract available.

2

Lower Risk of Hepatocellular Carcinoma With Tenofovir vs Entecavir in Patients With Chronic Hepatitis B.

Zhang H, Zeng W. Zhang H, et al. JAMA Oncol. 2019 Jun 1;5(6):914-915. doi: 10.1001/jamaoncol.2019.0641. JAMA Oncol. 2019. PMID: 31021391 No abstract available.

3

Frequent fragility of randomized controlled trials for HCC treatment.

Zhang H, Li J, Zeng W. Zhang H, et al. BMC Cancer. 2021 Apr 9;21(1):389. doi: 10.1186/s12885-021-08133-8. BMC Cancer. 2021. PMID: 33836710 Free PMC article.

4

HBV Infection Status and the Risk of Cholangiocarcinoma in Asia: A Meta-Analysis.

Zhang H, Zhu B, Zhang H, Liang J, Zeng W. Zhang H, et al. Biomed Res Int. 2016;2016:3417976. doi: 10.1155/2016/3417976. Epub 2016 Nov 23. Biomed Res Int. 2016. PMID: 27999794 Free PMC article. Review.

5

A novel predictor of severe dengue: The aspartate aminotransferase/platelet count ratio index (APRI).

Zhang H, Xie Z, Xie X, Ou Y, Zeng W, Zhou Y. Zhang H, et al. J Med Virol. 2018 May;90(5):803-809. doi: 10.1002/jmv.25021. Epub 2018 Feb 2. J Med Virol. 2018. PMID: 29315684

6

Roles of Interferons in Pregnant Women with Dengue Infection: Protective or Dangerous Factors.

Zhang H, He Z, Zeng W, Peng HJ. Zhang H, et al. Can J Infect Dis Med Microbiol. 2017;2017:1671607. doi: 10.1155/2017/1671607. Epub 2017 Sep 7. Can J Infect Dis Med Microbiol. 2017. PMID: 29081814 Free PMC article. Review.

7

Might Sorafenib combined with radiotherapy be better option for treating hepatocellular carcinoma with portal vein tumour thrombosis?

Zhang H. Zhang H. Liver Int. 2018 Feb;38(2):380. doi: 10.1111/liv.13566. Epub 2017 Sep 12. Liver Int. 2018. PMID: 28869711 No abstract available.

8

[Treatment options in HBeAg-positive chronic hepatitis B patients with a poor response to 24-week interferon monotherapy].

Wang X, Yuan G, Lai J, Yang N, Zhang H, Wang J, Zhou Y. Wang X, et al. Among authors: zhang h. Nan Fang Yi Ke Da Xue Xue Bao. 2015 Jun;35(6):807-11. Nan Fang Yi Ke Da Xue Xue Bao. 2015. PMID: 26111675 Clinical Trial. Chinese.

9

[Escitalopram for intervention of psychiatric adverse events during peginterferon-alfa-2a and ribavirin treatment for chronic hepatitis C].

Qi M, Zhou B, Su M, Pan J, Zhang H. Qi M, et al. Among authors: zhang h. Nan Fang Yi Ke Da Xue Xue Bao. 2013 Jul;33(7):1012-6. Nan Fang Yi Ke Da Xue Xue Bao. 2013. PMID: 23895843 Chinese.

10

Predicting sustained viral response to hepatitis C using a rapid and simple IL28B rs8099917 genotyping assay.

Li W, Zeng Y, Wang J, Zhou B, Zhang J, Zhang H, Li J, Wu Y, Hamoudi R, Zhou Y. Li W, et al. Among authors: zhang j, zhang h. Antiviral Res. 2012 Apr;94(1):54-6. doi: 10.1016/j.antiviral.2012.02.007. Epub 2012 Feb 22. Antiviral Res. 2012. PMID: 22387386

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

129,942 results

Search Page

Filters